275 related articles for article (PubMed ID: 31980117)
1. Role of Glucagon in Automated Insulin Delivery.
Wilson LM; Jacobs PG; Castle JR
Endocrinol Metab Clin North Am; 2020 Mar; 49(1):179-202. PubMed ID: 31980117
[TBL] [Abstract][Full Text] [Related]
2. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the effectiveness of glucagon for preventing hypoglycemia.
Castle JR; Engle JM; El Youssef J; Massoud RG; Ward WK
J Diabetes Sci Technol; 2010 Nov; 4(6):1305-10. PubMed ID: 21129324
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of a dual-hormone artificial pancreas with dosing adjustment during exercise compared with no adjustment and sensor-augmented pump therapy.
Jacobs PG; El Youssef J; Reddy R; Resalat N; Branigan D; Condon J; Preiser N; Ramsey K; Jones M; Edwards C; Kuehl K; Leitschuh J; Rajhbeharrysingh U; Castle JR
Diabetes Obes Metab; 2016 Nov; 18(11):1110-1119. PubMed ID: 27333970
[TBL] [Abstract][Full Text] [Related]
5. Role of Dual-Hormone Closed-Loop Delivery System in the Future.
Bally L; Thabit H; Hovorka R
Diabetes Technol Ther; 2016 Aug; 18(8):452-4. PubMed ID: 27500812
[No Abstract] [Full Text] [Related]
6. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
[TBL] [Abstract][Full Text] [Related]
7. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
[TBL] [Abstract][Full Text] [Related]
8. Randomized Outpatient Trial of Single- and Dual-Hormone Closed-Loop Systems That Adapt to Exercise Using Wearable Sensors.
Castle JR; El Youssef J; Wilson LM; Reddy R; Resalat N; Branigan D; Ramsey K; Leitschuh J; Rajhbeharrysingh U; Senf B; Sugerman SM; Gabo V; Jacobs PG
Diabetes Care; 2018 Jul; 41(7):1471-1477. PubMed ID: 29752345
[TBL] [Abstract][Full Text] [Related]
9. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
[TBL] [Abstract][Full Text] [Related]
10. Automated Insulin Delivery-The Light at the End of the Tunnel.
Turksoy K; Frantz N; Quinn L; Dumin M; Kilkus J; Hibner B; Cinar A; Littlejohn E
J Pediatr; 2017 Jul; 186():17-28.e9. PubMed ID: 28396030
[No Abstract] [Full Text] [Related]
11. Current Management of Glycemia in Children with Type 1 Diabetes Mellitus.
Sperling MA; Laffel LM
N Engl J Med; 2022 Mar; 386(12):1155-1164. PubMed ID: 35320645
[No Abstract] [Full Text] [Related]
12. Diabetes: Artificial pancreas--first head-to-head comparison of dual-hormone and single-hormone systems.
Holmes D
Nat Rev Endocrinol; 2015 Feb; 11(2):63. PubMed ID: 25511314
[No Abstract] [Full Text] [Related]
13. Development of a fully automated closed loop artificial pancreas control system with dual pump delivery of insulin and glucagon.
Jacobs PG; El Youssef J; Castle JR; Engle JM; Branigan DL; Johnson P; Massoud R; Kamath A; Ward WK
Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():397-400. PubMed ID: 22254332
[TBL] [Abstract][Full Text] [Related]
14. Automated glycemic control with the bionic pancreas in cystic fibrosis-related diabetes: A pilot study.
Sherwood JS; Jafri RZ; Balliro CA; Zheng H; El-Khatib FH; Damiano ER; Russell SJ; Putman MS
J Cyst Fibros; 2020 Jan; 19(1):159-161. PubMed ID: 31420176
[TBL] [Abstract][Full Text] [Related]
15. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
[TBL] [Abstract][Full Text] [Related]
16. Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.
Tang F; Wang Y
J Diabetes Sci Technol; 2017 Nov; 11(6):1112-1123. PubMed ID: 28728434
[TBL] [Abstract][Full Text] [Related]
17. Design of a dual-hormone model predictive control for artificial pancreas with exercise model.
Resalat N; El Youssef J; Reddy R; Jacobs PG
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2270-2273. PubMed ID: 28324962
[TBL] [Abstract][Full Text] [Related]
18. Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use.
Taleb N; Haidar A; Messier V; Gingras V; Legault L; Rabasa-Lhoret R
Diabetes Obes Metab; 2017 Jan; 19(1):13-23. PubMed ID: 27629286
[TBL] [Abstract][Full Text] [Related]
19. A coordinated control strategy for insulin and glucagon delivery in type 1 diabetes.
Herrero P; Bondia J; Oliver N; Georgiou P
Comput Methods Biomech Biomed Engin; 2017 Oct; 20(13):1474-1482. PubMed ID: 28929796
[TBL] [Abstract][Full Text] [Related]
20. Mini-Dose Glucagon as a Novel Approach to Prevent Exercise-Induced Hypoglycemia in Type 1 Diabetes.
Rickels MR; DuBose SN; Toschi E; Beck RW; Verdejo AS; Wolpert H; Cummins MJ; Newswanger B; Riddell MC;
Diabetes Care; 2018 Sep; 41(9):1909-1916. PubMed ID: 29776987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]